Key result
Female-specific factors like pregnancy and menopause linked to greater hypertensive cardiovascular vulnerability versus age-matched men.
Why the study?
Does estrogen therapy reduce cardiovascular disease events in postmenopausal women?
Does estrogen therapy reduce cardiovascular disease events in postmenopausal women?
Estrogen therapy is not recommended for cardiovascular risk reduction in postmenopausal women, and risk management should focus on lifestyle modifications and optimal control of lipids, glucose, and blood pressure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dixit et al. (2024) conducted a review in Hypertension. Sex-specific risk factors, including pregnancy and menopause, make females more vulnerable to adverse cardiovascular outcomes from hypertension than age-matched men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: